Pascal Wolter
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- Cutaneous Melanoma Detection and Management
- CAR-T cell therapy research
- Dermatology top 1%
- Cutaneous lymphoproliferative disorders research
Papers in
- Oncology 34
- Cutaneous Melanoma Detection and Management 9
- CAR-T cell therapy research 9
- Cancer Immunotherapy and Biomarkers 8
- Colorectal Cancer Treatments and Studies 4
-
- Renal cell carcinoma treatment 15
- Co-authors
- Patrick Schöffski (31 shared papers)Herlinde Dumez (17 shared papers)Benoit Beuselinck (17 shared papers)Cristiana Stefan (3 shared papers)Brigitte Decallonne (4 shared papers)Gregor E. G. Verhoef (6 shared papers)Hendrik Van Poppel (7 shared papers)Veerle Foulon (1 shared paper)
- Journals
- Annals of Oncology (8 papers)European Journal of Cancer (6 papers)Acta Oncologica (5 papers)Melanoma Research (5 papers)British Journal of Cancer (5 papers)
- Partner nations
- BelgiumUnited StatesFrance
In The Last Decade
Pascal Wolter
89 papers receiving 6.2k citations
Pascal Wolter's Hit Papers
Peers
Comparison fields: 5 of 112
- Oncology 2.8k
- Dermatology 500
- Cancer Research 620
- Molecular Biology 2.8k
- Pathology and Forensic Medicine 631
Countries citing papers authored by Pascal Wolter
This map shows the geographic impact of Pascal Wolter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Wolter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Wolter more than expected).
Fields of papers citing papers by Pascal Wolter
This network shows the impact of papers produced by Pascal Wolter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Wolter. The network helps show where Pascal Wolter may publish in the future.
Co-authors
The 25 scholars most cited alongside Pascal Wolter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 91 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib Hit paper breakdown → | 2014 | 2163 |
| 2 | Toward Minimal Residual Disease-Directed Therapy in Melanoma Hit paper breakdown → | 2018 | 525 |
| 3 | Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial Hit paper breakdown → | 2017 | 450 |
| 4 | 2017 | 246 | |
| 5 | 2015 | 220 | |
| 6 | 2018 | 219 | |
| 7 | 2008 | 172 | |
| 8 | 2011 | 150 | |
| 9 | 2010 | 131 | |
| 10 | 2012 | 99 | |
| 11 | 2010 | 99 | |
| 12 | 2018 | 91 | |
| 13 | 2013 | 83 | |
| 14 | 2011 | 78 | |
| 15 | 2006 | 74 | |
| 16 | 2013 | 71 | |
| 17 | 2012 | 59 | |
| 18 | 2013 | 56 | |
| 19 | 2014 | 52 | |
| 20 | 2008 | 50 |
About Pascal Wolter
Pascal Wolter is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Dermatology and Molecular Biology, having authored 91 papers that have together received 6.3k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (15 papers), Melanoma and MAPK Pathways (15 papers), Lymphoma Diagnosis and Treatment (10 papers), Cutaneous Melanoma Detection and Management (9 papers), CAR-T cell therapy research (9 papers), Cancer Immunotherapy and Biomarkers (8 papers), Cutaneous lymphoproliferative disorders research (7 papers) and Colorectal Cancer Treatments and Studies (4 papers). The work is most often cited by research in Oncology (2.8k citations), Dermatology (500 citations), Cancer Research (620 citations), Molecular Biology (2.8k citations) and Pathology and Forensic Medicine (631 citations). Pascal Wolter has collaborated with scholars based in Belgium, United States and France. Frequent co-authors include Patrick Schöffski, Herlinde Dumez, Benoit Beuselinck, Cristiana Stefan, Brigitte Decallonne, Gregor E. G. Verhoef, Hendrik Van Poppel, Veerle Foulon, M Bex and Peter Carmeliet. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, Acta Oncologica, Melanoma Research and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.